fp-c

We saw the amazing performance of the two mRNA COVID vaccines from Pfizer
and Moderna in their RCTs. As encouraging as trial performance is, we always want to see how those numbers hold up under large-scale, real-world pragmatic conditions. Well, we now have
three new pieces of information on that. And, for the cherry on top, we get evidence of
performance against asymptomatic infection! Dr. Jarvis does a quick review of the latest
evidence on vaccine performance.

See omnystudio.com/listener for privacy information.

December 4, 2001. A bad day, indeed. That’s the day the FDA issued a black box warning for droperidol, citing evidence of QT prolongation, Torsades de Pointes, and death. This was a surprise warning because droperidol had been extensively used by emergency medicine and anesthesiology for decades without apparent problems. Since this bad day, we’ve essentially been without droperidol. Fortunately, it’s back! Before we start using it again, we should take a look at what got this drug on the FDA’s radar. Dr. Jarvis reviews the literature about the “evidence” behind the warning and describes how his systems will be bringing droperidol back into practice.

See omnystudio.com/listener for privacy information.

The FDA just granted EUA for the Johnson and Johnson vaccine against COVID. This is a big deal because it is a one-shot vaccination that is much more stable than the two mRNA vaccines. Dr. Jarvis does a quick overview of the data submitted to the FDA for their approval.

See omnystudio.com/listener for privacy information.

LIVE from a virtual Texas EMS Conference, we bring you a session moderated by Mike featuring Drs. Jeff Jarvis, Jason Pickett, and Heidi Abraham. This is the highly anticipated Part Deux of a session we all did at the Texas EMS Conference in Fort Worth 2019… back before “the situation” when we could all meet in person like civilized humans. We discussed a variety of topics including the new DEA rules about controlled substances, the new AHA guidelines, and lots of other goodies. But mostly, we just had fun.

See omnystudio.com/listener for privacy information.

Ketamine only intubation has been promoted by some as a safe approach to airway management in patients with anatomically or physiologically difficult airways. It turns out Dr. Jarvis has some thoughts on the subject. He uses a 2020 paper by Dr. Driver entitled “Success and Complications of the Ketamine-Only Intubation Method in the Emergency Department” to discuss this concept.

If you like what you hear, please give us a 5-star rating wherever you get your podcasts and tell your friends to subscribe (or download each episode several times… we’ve gotta beat Second Shift after all). All of our podcasts are now also released in video format on the FlightbridgeED YouTube channel. Take a look, subscribe, and give us a ‘thumbs up’.

As always, we want to hear your feedback and questions/comments. You can reach us at @DrJeffJarvis, jeff.jarvis@flightbridgeed.com and @MikeVerkest, mike.verkest@flightbridgeed.com.

Thanks y’all!

See omnystudio.com/listener for privacy information.

Children are often considered to be just small adults, much to the dismay of pediatricians everywhere. But when it comes to peri-intubation cardiac arrest, is it true? We know that, in adults, peri-intubation hypoxia is a strong predictor of cardiac arrest. Is this true in pediatric patients?

This episode features another oral board case with Dr. Erin Lincoln (@ErinTWL) and live discussion with Mike (@MikeVerkest), Jeff (@DrJeffJarvis) and special guest Dr. Peter Antevy (@HandtevyMD). Our live segment had lots of great listener questions which led Peter and Jeff to go deep down the rabbit hole of safe intubation practices.

If you like what you hear, please give us a 5-star rating wherever you get your podcasts and tell your friends to subscribe (or download each episode several times… we’ve gotta beat Second Shift after all). All of our podcasts are now also released in video format on the FlightbridgeED YouTube channel. Take a look, subscribe, and give us a ‘thumbs up’.

As always, we want to hear your feedback and questions/comments. You can reach us at @DrJeffJarvis, jeff.jarvis@flightbridgeed.com and @MikeVerkest, mike.verkest@flightbridgeed.com.

See omnystudio.com/listener for privacy information.

Dr. Jarvis and Mike Verkest are joined by a trio of guests to discuss the literature surrounding both the Pfizer BionTech and Moderna Vaccines. Dr. Ritu Sahni, Dr Veer Vithilani and Dr. Remle Crowe round out the panel. This episode is nearly 2 hours in length, and we hope we answered any questions you might have in a non-bias way. Feel free to share this episode or any of the mRNA series of podcasts and live broadcasts we have done this month. We appreciate you listening.

See omnystudio.com/listener for privacy information.

This episode was a LIVE media broadcast discussing a double-blind trial of IM Droperidol, Ziprasidone and Lorazepam for acute undifferentiated agitation in the emergency department. Join Mike and Jeff as they discuss the paper, take questions from the viewers and tease the newly released Standard of Care Podcast! Thank you for listening, sharing, rating and reviewing all the FlightBridgeED podcasts! We appreciate you being on this journey with us!

See omnystudio.com/listener for privacy information.

Part pre-recorded, part LIVE! Dr. Jeff Jarvis, Dr. Jason Pickett, and Mike Verkest discuss the results of the Resuscitation Outcomes Consortium TXA in TBI Trial. Thanks for coming to the channel! Be sure to subscribe here and wherever you listen to podcasts!

See omnystudio.com/listener for privacy information.

Have you had patients recently with repeat EMS calls and lots of ED visits for nausea and vomiting? They say the only thing th works for them is scalding hot showers and that drug that starts with a "D". Did they just happen to smoke a lot of weed? In this episode, Dr. Jarvis discusses cannabinoid hyperemesis syndrome and reviews an RCT comparing topical capsaicin cream (yes... the stuff of pepper spray fame) vs placebo.

See omnystudio.com/listener for privacy information.

Mike and Dr. Jarvis are joined by Drs. David Wampler and Emily Kidd to discuss their study on the performance characteristics of the VAN score for detecting large vessel strokes. Drs. Jarvis and Kidd run through a case of a patient with stroke to discuss the thought process of an emergency physician.

See omnystudio.com/listener for privacy information.

We talk headaches in this episode, specifically an RCT comparing haloperidol to placebo for benign headache. Joining us for this episode is special guest Dr. Erin Lincoln (@ErinTWL), EM resident and paramedic. Drs Jarvis and Lincoln will go through an oral boards-type case of a 45-year-old woman with a headache. We’ll include a review of the literature on headache treatments, hit on why opioids aren’t recommended, and discuss the differential diagnosis of headaches and the red flags that will help find those “can’t miss” diagnoses. This is a new format for us. We really, really want your feedback. Do you like the oral boards-style interview? Drop us a note on Twitter: @MikeVerkest, @DrJeffJarvis, or an email mike.verkest@flightbridgeed.com or jeff.jarvis@flightbridgeed.com. And don’t forget to give us a review on Apple Podcasts to help other likeminded clinicians find our show.

See omnystudio.com/listener for privacy information.

VL vs Augmented DL with Special Guest: Dr. George Kovacs. We’re starting a new format with this episode. We kick things off with a review of a paper: Brown CA, et al. Video Laryngoscopy Compared to Augmented Direct Laryngoscopy in Adult Emergency Department Tracheal Intubations: A National Emergency Airway Registry (NEAR) Study. Acad Emerg Med. 2020; 27: 100-108. After discussing the paper, we have an amazing interview with Dr. George Kovacs (@kovacsgj) to discuss the differences between types of VL devices. He drops some great pearls on some tips for intubation success. Then Mike joins us for a discussion of the paper and interview. We hope you like the new format. Please drop us a line and let us know what you think! As always, please subscribe and give us a 5-star rating on Apple Podcasts. We’d love to hear your thoughts, questions, and suggestions. Join us on Twitter: @MikeVerkest, @DrJeffJarvis, @EMSLighthouse

See omnystudio.com/listener for privacy information.

There has been a lot of talk about the benefits of TXA in major trauma with small differences in outcomes. If you’re looking for a big treatment benefit for TXA, look no further than the very sexy nose bleeds. This is an easy and safe intervention that EMS can provide that makes a real difference in a growing number of patients. If you like what you hear, please give us a 5-star rating on Apple Podcasts and other premier podcast purveyors and tell your friends to subscribe (or download each episode several times… we’ve gotta beat Second Shift after all).

See omnystudio.com/listener for privacy information.

Are you worried about what might happen in your jurisdiction if COVID breaks out in your nursing homes? You should be. Dr. Jarvis reviews a NEJM paper in this episode: Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. Afterward, he’s joined by a special guest, Dr. Jason Pickett. Dr. Pickett is the deputy medical director for Austin-Travis County EMS, assistant local health authority for Austin Public Health, and the host of the EMS podcast with the longest name ever. As always, please subscribe and give us a 5-star rating on Apple Podcasts. We’d love to hear your thoughts, questions, and suggestions. Join us on Twitter: @MikeVerkest, @DrJeffJarvis, @EMSLighthouse.

See omnystudio.com/listener for privacy information.

We are living, in a COVID world. And I am a COVID doc. This is a special episode of the EMS Lighthouse Project Podcast. Since the entire Jarvis household is quarantined in our bunker in Central Texas, I brought the family together to discuss how this such a short little piece of RNA has changed our world. Oh, and we talk about the MMWR report from Singapore that, apparently, got the CDC to change its stance on the use of public face masks. If you like what you hear, please give us a 5-star rating on Apple Podcasts and other premier podcast purveyors and tell your friends to subscribe. Most importantly, stay safe out there. Thank you for stepping up and caring for others in these difficult times. We appreciate each one of you. I’ve never been prouder to be in EMS.

See omnystudio.com/listener for privacy information.

Remember our podcast where we talked about amiodarone and lidocaine improving survival from arrest when given IV but not IO? Wait! There’s more. Another paper dropped looking at the same thing but with epinephrine instead of anti-dysrhythmics. Does this paper show the same thing? Is there really something to this IV superiority thing? Dr. Jarvis breaks this new paper down. As always, please subscribe and give us a 5-star rating on Apple Podcasts. We’d love to hear your thoughts, questions, and suggestions. Join us on Twitter: @MikeVerkest, @DrJeffJarvis, @EMSLighthouse

See omnystudio.com/listener for privacy information.

Remember Episode 12 where we reviewed a Houston paper on DSD showing worse outcomes with DSD? At the end of that pod, I spoke about an ongoing RCT trial comparing DSD to standard therapy AND vector change defibrillation. Well, the pilot phase of that trial is over and has JUST been published. It has some surprising preliminary results. Join us and find out how that study is going. If you like what you hear, please give us a 5-star rating on Apple Podcasts and other premier podcast purveyors and tell your friends to subscribe (or download each episode several times… we’ve gotta beat Second Shift after all).

See omnystudio.com/listener for privacy information.

Have you ever given adenosine to a patient in SVT? Yeah? Did they like it? I didn’t think so. You’ve probably also given up trying to use the Valsalva maneuver because you’ve found it doesn’t work very often. Wouldn’t it be great if there were a way to make the Valsalva more effective and, perhaps, avoid kicking the patient in the chest with adenosine? Dr. Jarvis reviews a paper in this episode that may offer just this. If you like what you hear, please give us a 5-star rating on Apple Podcasts and other premier podcast purveyors and tell your friends to subscribe (or download each episode several times… we’ve gotta beat Second Shift after all).

See omnystudio.com/listener for privacy information.

The final part of our coverage of some of the research from NAEMSP2020 in San Diego. If you missed any of the first three episodes, be sure to download them and take a listen. They were great! In this episode, we wrap up the series with outstanding discussions. We discuss the epidemiology of pediatric trauma activations with San Antonio’s Dr. Craig Cooley and finish up with a discussion with Dr. Henry Wang. Dr. Wang talks to us through an oral abstract he presented here on a secondary analysis looking at the impact of FPS in the PART trial comparing ET and King LT in cardiac arrest. As a bonus, he talks us through the original PART trial for which he was the principal investigator. As always, we want to hear your feedback. Let us know what you think: @MikeVerkest, @DrJeffJarvis, and @EMSLigthouse. Subscribe and give us a great rating on Apple Podcast.

See omnystudio.com/listener for privacy information.